rs267606916
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_153240.5(NPHP3):c.2104C>T(p.Arg702*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000961 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_153240.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251404Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135874
GnomAD4 exome AF: 0.0000958 AC: 140AN: 1461560Hom.: 0 Cov.: 31 AF XY: 0.0000949 AC XY: 69AN XY: 727084
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74326
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
Observed with a pathogenic variant in a patient with a nephronophthisis-related ciliopathy in published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Halbritter et al., 2013); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 19303681, 32040628, 23559409) -
- -
Nephronophthisis Pathogenic:1Other:1
- -
This sequence change creates a premature translational stop signal (p.Arg702*) in the NPHP3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP3 are known to be pathogenic (PMID: 18371931, 23559409). This variant is present in population databases (rs267606916, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with nephronophthisis (PMID: 19303681). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2640). For these reasons, this variant has been classified as Pathogenic. -
NPHP3-related disorder Pathogenic:1
PVS1, PM2, PP1 -
Nephronophthisis 3;C2673885:NPHP3-related Meckel-like syndrome;C3715199:Renal-hepatic-pancreatic dysplasia 1 Pathogenic:1
- -
NPHP3-related Meckel-like syndrome Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Joubert syndrome and related disorders Pathogenic:1
Variant summary: NPHP3 c.2104C>T (p.Arg702X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position are associated with Nephronophthisis in HGMD. The variant allele was found at a frequency of 4.8e-05 in 251404 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in NPHP3 causing Joubert Syndrome And Related Disorders (4.8e-05 vs 0.0004). c.2104C>T has been reported in the literature in individuals affected with Nephronophthisis and at-least one heterozygous individual with a diagnosis of Joubert Syndrome And Related Disorders (examples: Simpson_2009, Halbritter_2013, Iorio_2020). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Nephronophthisis 3 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at